F. Okada et al., ANTIEMETIC EFFECTS OF SEROTONERGIC 5-HT1A-RECEPTOR AGONISTS IN SUNCUS-MURINUS, Japanese Journal of Pharmacology, 64(2), 1994, pp. 109-114
The antiemetic effects of six serotonergic 5-HT1A-receptor agonists, 8
-hydroxy-2-(di-n-propylamino)tetrarin (8-OH-DPAT), yl}-2,3,4,5-tetrahy
dro-1,4-benzoxazepine-3,5-dione (SUN8399), buspirone, gepirone, ipsapi
rone and tandospirone, against motion sickness were investigated in Su
ncus murinus. Subcutaneous injection of all six agonists completely an
d dose-dependently suppressed motion-induced emesis. Pretreatment with
8-OH-DPAT or SUN8399 dose-dependently inhibited emesis elicited by ni
cotine (4.0 mg/kg, s.c.), veratrine (0.7 mg/kg, s.c.), cisplatin (20 m
g/kg, i.p.) and copper sulfate (40 mg/kg, p.o.). These results suggest
that serotonergic 5-HT1A-receptor agonists are effective as anti-moti
on sickness drugs, and these drugs may block a common mechanism(s) for
the emetic reflex of the suncus because the antiemetic effects of the
5-HT1A-receptor agonists were exerted irrespective of the stimulus.